| Mrs Sandra Kay Brooks-walker, | |
|
1403 Metro Dr Ste C1, Alexandria, LA 71301-3446 | |
| (318) 625-7467 | |
| (318) 625-7420 |
| Full Name | Mrs Sandra Kay Brooks-walker |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1403 Metro Dr Ste C1, Alexandria, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093285058 | NPI | - | NPPES |
| 81-4577697 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 8122 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sandra Kay Brooks-walker, 1403 Metro Dr Ste C1, Alexandria, LA 71301-3446 Ph: (318) 625-7467 | Mrs Sandra Kay Brooks-walker, 1403 Metro Dr Ste C1, Alexandria, LA 71301-3446 Ph: (318) 625-7467 |
News Archive
Medical co-morbidities, when women have one or more medical conditions, are found to be an important factor associated with direct maternal deaths, suggests a new study published today (9 January) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
Children with Duchenne muscular dystrophy face a future of rapidly weakening muscles, which usually leads to death by respiratory or cardiac failure before their 30th birthday. While researchers are hopeful that gene therapy could eventually evolve into an effective treatment, few have targeted the heart of the problem as much as Dongsheng Duan, PhD.
The mechanism used by the bacteria that cause anthrax, bubonic plague and typhoid fever to avoid detection and destruction by the body's normal immune response, leading to life-threatening bacterial infections, has been identified by researchers at the University of California, San Diego (UCSD) School of Medicine.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.
› Verified 4 days ago
Dr. Cindy Escandell, PSYD Counselor Medicare: Not Enrolled in Medicare Practice Location: 6016 Navaho Trl, Alexandria, LA 71301 Phone: 318-451-1110 Fax: 318-448-9088 | |
Kenya Smith, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1403 Metro Dr Ste G, Alexandria, LA 71301 Phone: 318-445-9019 Fax: 318-445-1098 | |
Laura Neal, Counselor Medicare: Not Enrolled in Medicare Practice Location: 710 Versailles Blvd, Alexandria, LA 71303 Phone: 318-449-4474 | |
Mr. Jason Asa Goens, MS, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4606 Lee St, Alexandria, LA 71302 Phone: 318-664-8293 | |
Shane Bolton, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1450 Peterman Dr Ste A, Alexandria, LA 71301 Phone: 318-473-4328 | |
Roshonda Ross, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3600 Jackson St Ste 111b, Alexandria, LA 71303 Phone: 318-483-4155 | |
April M Johnson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4606 Lee St, Alexandria, LA 71302 Phone: 318-441-1105 |